Literature DB >> 776537

A double-blind study of flupenthixol ('Fluanxol') in general practice.

I Ovhed.   

Abstract

A double-blind crossover trial was carried out in the general practice to compare the effectiveness of flupenthixol and placebo in 43 patients with mild to moderate anxiety/depression states. Patients received either 0.5 mg flupenthixol or identical placebo tablets 2 to 4-times daily for 2 weeks and were then crossed over to the alternative preparation for a further 2 weeks. A simple 5-point rating scale was used to assess patients' symptoms at first visit and at subsequent follow-up. Even though there was a high placebo response, the results showed flupenthixol to be significantly more effective than placebo in relieving symptoms. Few side-effects were reported and were mild in nature.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776537     DOI: 10.1185/03007997609109295

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  2 in total

1.  The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.

Authors:  S Kutcher; G Papatheodorou; S Reiter; D Gardner
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

2.  Methyl 2-[4-(tri-fluoro-meth-yl)phenyl-sulfan-yl]benzoate.

Authors:  Thammarse S Yamuna; Jerry P Jasinski; Brian J Anderson; H S Yathirajan; Manpreet Kaur
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.